探索一些生物活性化合物的有效性作为抗高血压药物:通过DFT,分子对接和分子动力学模拟进行洞察性的评估
Sourav Majumdar1, Anup Pramanik1
1Department of Chemistry, Sidho-Kanho-Birsha University, Purulia, 723104 India.
In silico pharmacology
|December 27, 2024
概括
这项研究使用分子对接和模拟探索了25种抗高血压药物候选药物. 弗卢纳利津对标蛋白具有显著影响,表明其作为有效高血压治疗的潜力.
科学领域:
- 药理学和药物化学 药理学和药物化学
- 计算机化药物发现技术
背景情况:
- 高血压治疗依赖于各种药物类别,包括通道阻断剂和ACE抑制剂.
- 了解药物向相互作用对于开发有效的抗高血压疗法至关重要.
研究的目的:
- 通过in-silico方法评估25种药物配体的抗高血压潜力.
- 调查结构-性质关系,并预测候选分子的药物相似性.
- 评估顶级候选药物与标蛋白的动态相互作用.
主要方法:
- 对人类ACE受体 (1O8A) 和通道 (3LV3) 的分子对接.
- 密度函数理论 (DFT) 用于结构属性分析.
- 在中进行ADMET预测,包括符合Lipinski的第5规则.
- 100 ns的分子动力学 (MD) 模拟用于排名最高的配体.
主要成果:
- 所有25个配体都遵守了利宾斯基的第5规则,这表明口服生物可用性良好.
- 分子对接确定了与ACE和通道目标的强有力的相互作用.
- MD模拟显示了连接物flunarizine对蛋白质的显著影响.
结论:
- 研究的配体显示出有前途的抗高血压特性.
- 弗鲁纳瑞 (Flunarizine) 成为进一步发展高血压治疗的关键候选者.
- 计算方法为抗高血压药物设计提供了宝贵的见解.
相关概念视频
Structure-Activity Relationships and Drug Design
412
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
412
Antihypertensive Drugs: Action of Diuretics
566
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
566
Antihypertensive Drugs: Vasodilators
426
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
426
Antihypertensive Drugs: Action of Calcium Channel Blockers
389
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
389
Antihypertensive Drugs: Action of β1 Blockers
258
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
258
Antihypertensive Drugs: Angiotensin II Receptor Blockers
528
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
528


